ESR2 and atherosclerosis: Moreover, the exposure of human macrophages to an ERβ-selective agonist led to a robust decrease in the level of extracellular heat shock protein 27, a biomarker of atherosclerosis [57], while the ERα-selective agonists did not show such an effect [58].